|
Market Closed -
Euronext Paris
11:55:00 2026-10-14 EDT
|
After hours 15:38:06 | |||
| 1.320 EUR | +3.94% |
|
1.314 | -0.45% |
| 10-12 | Crossject: No market launch of Zepizure before H127 at best | AL |
| 09-25 | Crossject: H126. Quid novi sub sole? Not much. | AL |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Drug Delivery Systems
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 77.4M | - | - | |||
| 178B | |||||
| 119B | |||||
| 108B | |||||
| 75.27B | |||||
| 62.99B |
- Stock Market
- Stocks
- ALCJ Stock
- Charts Crossject
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
